The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
TORAVA trial: Lessons from this trial in the two control arms, sunitinib and bevacizumab in combination with interferon.
Bernard J. Escudier
No relevant relationships to disclose
David Perol
No relevant relationships to disclose
Celine Ferlay
No relevant relationships to disclose
Gwenaelle Gravis
No relevant relationships to disclose
Christine Chevreau
No relevant relationships to disclose
Remy Delva
No relevant relationships to disclose
Jacques-Olivier Bay
No relevant relationships to disclose
Lionel Geoffrois
No relevant relationships to disclose
Ellen Blanc
No relevant relationships to disclose
Sylvie Negrier
No relevant relationships to disclose